MAPS

MAPS Responds to FDA Progress on MDMA-Assisted PTSD Therapy

Denver, Colorado, USA — August 10, 2026 Multidisciplinary Association for Psychedelic Studies (MAPS) responded to reports that Resilient Pharmaceuticals,...

By cGxPwire Editor
August 12, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

MAPS

MAPS Responds to FDA Progress on MDMA-Assisted PTSD Therapy